Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. - Wikidata - awgldk - TriplyDB

Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs.

Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs.

http://www.wikidata.org/entity/Q33201285

about

Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations Rapid disintegrating tablets of simvastatin dispersions in polyoxyethylene-polypropylene block copolymer for maximized disintegration and dissolution Microemulsions for oral administration and their therapeutic applications Solubility enhancement of simvastatin by arginine: thermodynamics, solute-solvent interactions, and spectral analysis.Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability Design and evaluation of a self-microemulsifying drug delivery system for apigenin.The preparation and evaluation of self-nanoemulsifying systems containing Swietenia oil and an examination of its anti-inflammatory effects Preparation and evaluation of SEDDS and SMEDDS containing carvedilol.Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.Application of mixture experimental design to simvastatin apparent solubility predictions in the microemulsifion formed by self-microemulsifying.Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS).Development and characterization of nanostructured mists with potential for actively targeting poorly water-soluble compounds into the lungs.Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex.Lacidipine self-nanoemulsifying drug delivery system for the enhancement of oral bioavailability.Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.Characterization and evaluation of a self-microemulsifying drug delivery system containing tectorigenin, an isoflavone with low aqueous solubility and poor permeability.Systematic development of self-emulsifying drug delivery systems of atorvastatin with improved bioavailability potential.Effects of highly hygroscopic excipients on the hydrolysis of simvastatin in tablet at high relative humidity.Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation.Improving tenoxicam solubility and bioavailability by cosolvent system Preparation and evaluation of self-nanoemulsifying tablets of carvedilol.Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation.Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation.Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.Statins therapy: a review on conventional and novel formulation approaches.Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.Isoflavones: estrogenic activity, biological effect and bioavailability.Preclinical formulations: insight, strategies, and practical considerations.Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS).

P2860

Q24610012-15D28E33-EA2E-48BD-BCB3-9D12FB66F53F Q24610099-56D823C9-FDC3-4F17-A054-FB4206F40D63 Q24647645-308CE7E9-4E1C-46B5-955B-2F12A646E8F5 Q28084784-0235779D-B022-4032-86D5-FDC1B221BEF6 Q28822355-30E594AF-41EB-426A-BCC5-CF8BCF8C57B8 Q29307905-D73F53BC-9741-49C5-BC92-36968327F0E1 Q31067924-46772121-0F37-45AA-9CA0-B3420838A2DA Q33300108-1FA9805F-F48B-45F5-9FEE-8453D7FC9840 Q33681221-EB421E07-2B83-415C-BCC9-B99AE5C620C0 Q33986021-DA61C075-7F0A-43BE-8F2B-3FBB02F5C9C6 Q34274270-D2D1337E-C988-421A-BF23-FE91664B50C8 Q34354103-6E4CFE26-1432-4705-95E9-60DC791143FD Q34459102-8770B27A-A9FA-4052-A9A4-35B38F9A1D43 Q34562249-3C8764B2-36DE-418E-A5D3-A48AD183AF62 Q34692340-B567996B-FBCF-4739-A3BE-EB1AD52623AD Q34728544-F22837FC-58E2-4C97-A411-A7A2CBB4FE3E Q34748536-B8421C21-10F8-4152-BFEA-996C4ABB5A81 Q34890252-433B38C8-0754-4615-A063-F9476261D037 Q35318247-691BEA56-4005-47D7-B3D1-63D5E429FC24 Q35488199-74DA700D-1CCA-4EB6-8BC9-F0D62E755ACE Q35677172-06E24206-054B-49B4-885E-A71321872BB7 Q35771256-F907030F-B32F-4410-BA82-347992528270 Q36137372-49E8EA10-9967-41D8-B0F0-5FF5F6C298D2 Q36304680-1D658BD5-1E61-469B-9055-241C5C4054D4 Q36482118-5E280578-69C6-4811-9F47-23A976133337 Q36943776-9E56A38F-0EAE-4FFF-B30B-6119AF9E9D40 Q37021478-D4B05048-50EB-4701-A48D-5FC757952985 Q37095744-32EA6440-F12C-4F51-9546-2E92110FBE26 Q37146165-2DE7A8A1-0986-4B82-8A65-203394A1B19B Q37146180-FB3072E1-84DC-4571-A8AB-7B056069AEAE Q37424003-5146228B-B1F1-40A9-BDD4-CD9E4B6459C7 Q37591913-CC722A18-84F7-4FC0-840D-D5F2A5EBEE49 Q37702234-AE5CCD39-46DB-4F3D-8877-0450EDFB7761 Q37805592-4D332057-1BCA-4CF1-9F6F-67D4A955798B Q37896125-9C0BD9C7-E1AE-4BC8-A85A-7EEBBA406520 Q37988960-DF981220-2A10-43A6-A6A2-F0BF741F1E18 Q38050511-85F91E85-AC41-4105-B98C-BFBC4C73FEF5 Q38060653-D7B47446-6E46-4A98-8BAD-B3487F6A6D97 Q38219628-56D6A7BA-4612-442F-BEEB-019749077FFA Q38448902-0A099D44-8B2B-4022-8F17-C8DE6507D258

P2860

Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs.

http://www.wikidata.org/entity/Q33201285

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Development of self-microemuls ...... of simvastatin in beagle dogs.

@ast

Development of self-microemuls ...... of simvastatin in beagle dogs.

@en

type

label

Development of self-microemuls ...... of simvastatin in beagle dogs.

@ast

Development of self-microemuls ...... of simvastatin in beagle dogs.

@en

prefLabel

Development of self-microemuls ...... of simvastatin in beagle dogs.

@ast

Development of self-microemuls ...... of simvastatin in beagle dogs.

@en

P1433

Q33201285-D199B892-05EE-4099-85FD-17C714E4ABAF

P1476

Q33201285-6A253877-0557-4837-ABD2-C8E28D18BA3C

P2093

Q33201285-1AC119AE-C08D-4E04-8022-34F7D9E3CAA4

Q33201285-25FE3F8F-C5F5-420C-B21D-92A54181FBEC

Q33201285-29F1625B-56AA-43E0-8B95-1A22DF30FB2B

Q33201285-552A843E-2537-4233-BC89-95FA537C8DE9

Q33201285-706F0ECE-7CF7-4C6F-B82C-FF08D51E0E9D

Q33201285-7AF78F26-F15C-4CA3-BB5B-5C966886D6A7

Q33201285-8808CB21-A19F-4596-97AD-7B7CD348F440

Q33201285-D00CFDBA-8021-4724-9B24-8E19818F30DA

P304

Q33201285-D67C5C6D-7B5F-4B15-9276-754237FCBB69

P31

Q33201285-D103605B-8957-4DD7-9078-698CD425389F

P356

Q33201285-A341EFC1-E0A1-4DD1-B8F8-05E0D460CAB7

P407

Q33201285-B24DAA17-7098-4C09-BB1F-B4E27E268CFC

P433

Q33201285-18B6F060-1493-4CEE-9FEC-85278E8A637C

P478

Q33201285-45C64E9E-8E28-4CFC-A654-9BD476080DC4

P577

Q33201285-A4A749C3-4AE3-44E5-A90F-52A512735D54

P5875

Q33201285-469DAE14-1192-4CC7-B832-9F27C40DE660

P698

Q33201285-EA612D0A-3BC9-49F6-BB69-0BC2D3297977

P921

Q33201285-67F2DD43-B019-46F5-B361-98B5444DF298

P356

J.IJPHARM.2003.12.028

P1433

International Journal of Pharmaceutics

P1476

Development of self-microemuls ...... of simvastatin in beagle dogs.

@en

P2093

Bok Ki Kang

http://www.w3.org/2001/XMLSchema#string

Gilson Khang

http://www.w3.org/2001/XMLSchema#string

Hai Bang Lee

http://www.w3.org/2001/XMLSchema#string

Jin Soo Lee

http://www.w3.org/2001/XMLSchema#string

Sang Young Jeong

http://www.w3.org/2001/XMLSchema#string

Se Kang Chon

http://www.w3.org/2001/XMLSchema#string

Soon Hong Yuk

http://www.w3.org/2001/XMLSchema#string

Sun Hang Cho

http://www.w3.org/2001/XMLSchema#string

P304

65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJPHARM.2003.12.028

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

274

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8628634

http://www.w3.org/2001/XMLSchema#string

P698

15072783

http://www.w3.org/2001/XMLSchema#string

P921